Investment Rating - The investment rating for the company is "Accumulate" [5] Core Insights - The company has disclosed details regarding its dual listing in the US, aiming to enhance global trading liquidity. The recent appointments of the CFO and TUMI President are expected to positively impact performance, with Q4 2025 results anticipated to continue the improvement trend seen in Q3 [2][9] - The company plans to issue American Depositary Shares (ADS) for its dual listing, with the issuance period lasting until the end of the shareholders' annual meeting on June 4, 2026. The new shares will be priced at a discount of no more than 15% from the last closing price [9] - The company expects to see a recovery in valuation due to the dual listing and anticipates that Q4 2025 will show year-on-year revenue growth, particularly in the Indian and Chinese markets, while North America is expected to see a reduced decline compared to Q3 [9] Financial Summary - Total revenue projections (in million USD) for 2024A, 2025E, 2026E, and 2027E are 3589, 3481, 3651, and 3824 respectively, with year-on-year changes of -2.5%, -3.0%, +4.9%, and +4.7% [4] - Gross profit is projected to be 2152, 2074, 2187, and 2298 million USD for the same years, with corresponding changes of -3.6%, -3.6%, +5.5%, and +5.1% [4] - Net profit attributable to the parent company is expected to be 346, 268, 301, and 336 million USD, reflecting year-on-year changes of -17.1%, -22.3%, +12.2%, and +11.6% [4] - The company is projected to have a PE ratio of 10.56, 13.60, 12.12, and 10.86 for the years 2024A, 2025E, 2026E, and 2027E respectively [4] Market Data - The current stock price is 19.96 HKD, with a market capitalization of 29,266 million HKD and a total share count of 1,466 million [6]
新秀丽（01910）：美股双重上市细则披露，2位高管任命落地